GSE171857
Evaluation the targeted nanobubbles mediated LND against hepatocellular carcinoma by sonodynamic therapy with RNA-Seq
Sonodynamic therapy is an important approach in the treatment of hepatocellular carcinoma. A novel targeted nanobubbles loaded with HMME and LND was structured as sensibilizer, characterized the properties, and studied therapeutic effect on hepatocellular carcinoma. Next-generation high throughput RNA sequencing (RNA-Seq) was performed to accurately analyze the differential expression of mRNAs and lncRNA targets in hepatocellular carcinoma after sonodynamic therapy. Overall design: HepG2  cells and Huh7 cells were used for the research. The cells were transfected using the nanoparticles with the aid of low-frequency ultrasound (LFUS) exposure. Two groups of  cells were analyzed using high-throughput RNA sequencing.